William Marshall

William (Bill) Marshall is an experienced medical professional currently serving as the Chief Medical Officer at JucaBio since February 2024. Previously, William held the position of Vice President of Medical at CinCor Pharma, Inc., now a subsidiary of AstraZeneca, from June 2022 to August 2023. William's academic background includes a long tenure as an Associate Professor at the University of Massachusetts from June 2000 to July 2022, where responsibilities included directing the Infectious Disease fellowship. William's industry experience features roles such as Vice President of Clinical Development at AlloVir, focusing on Phase 2 and Phase 3 clinical studies, and providing medical expertise in various leadership roles across companies such as resTORbio, Alexion Pharmaceuticals, and Merck. William earned a Clinical/Research Fellowship in Infectious Disease at Harvard Medical School and holds an MD from Columbia University Vagelos College of Physicians and Surgeons, as well as an AB in Biology from Harvard University.